Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 4/2019

Content (25 Articles)

Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018

Nayyra Fatani, Christopher Fanikos, Clara Ting, Leo F. Buckley, John Fanikos

Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study

Dominick J. Angiolillo, Deepak L. Bhatt, Frank Lanza, Byron Cryer, Jin-fei Dong, Walter Jeske, Ronald R. Zimmerman, Estela von Chong, Jayne Prats, Efthymios N. Deliargyris, Upendra Marathi

Open Access Stroke

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

Axel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, Lars Wallentin, Stefan K. James, Andrzej Budaj, Hugo A. Katus, Anders Himmelmann, Kurt Huber, Agneta Siegbahn, Robert F. Storey, Richard C. Becker

Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy

Jessica L. Cohen, Elena Thompson, Liron Sinvani, Andrzej Kozikowski, Guang Qiu, Renee Pekmezaris, Alex C. Spyropoulos, Jason J. Wang

Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry

Yuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, Syunsuke Saga, Hidewo Amano, Toru Takase, Seiichi Hiramori, Kitae Kim, Maki Oi, Masaharu Akao, Yohei Kobayashi, Mamoru Toyofuku, Toshiaki Izumi, Tomohisa Tada, Po-Min Chen, Koichiro Murata, Yoshiaki Tsuyuki, Tomoki Sasa, Jiro Sakamoto, Minako Kinoshita, Kiyonori Togi, Hiroshi Mabuchi, Kensuke Takabayashi, Yusuke Yoshikawa, Hiroki Shiomi, Takao Kato, Takeru Makiyama, Koh Ono, Yukihito Sato, Takeshi Kimura

Assessing patient preferences for switching from warfarin to direct oral anticoagulants

Jack N. Wright, Sara R. Vazquez, Kibum Kim, Aubrey E. Jones, Daniel M. Witt

Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement

Kajetan Grodecki, Karol Zbroński, Elżbieta Przybyszewska-Kazulak, Anna Olasińska-Wiśniewska, Radosław Wilimski, Bartosz Rymuza, Piotr Scisło, Paweł Czub, Dominika Koper, Janusz Kochman, Katarzyna Pawlak, Olga Ciepiela, Marek Grygier, Marek Jemielity, Maciej Lesiak, Krzysztof J. Filipiak, Grzegorz Opolski, Zenon Huczek

Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement?

Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jakub Benko, Ján Staško, Peter Kubisz, Peter Galajda, Marián Mokán

Description of anti-Xa monitoring practices during low molecular weight heparin use

Albert Lin, Sara R. Vazquez, Aubrey E. Jones, Daniel M. Witt

Open Access Stroke

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings

Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, Sanghun Iwashiro, Yoko Kidani, Yutaka Okayama, Toshiyuki Sunaya, Shoichiro Sato, Satoshi Yamanaka

Ticagrelor after pharmacological thrombolysis in patients with ST-segment elevation myocardial infarctions: insight from a trial sequential analysis

Mohammed Osman, Babikir Kheiri, Amanda Jo Shigle, Maryam Saleem, Khansa Osman, Partho P. Sengupta, Jason A. Moreland

Venous thromboembolism 2011–2018 in Stockholm: a demographic study

Per Wändell, Tomas Forslund, Helene Danin Mankowitz, Anna Ugarph-Morawski, Staffan Eliasson, Frieder Braunschwieg, Margareta Holmström

Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency

A. Moret, Ángel Zúñiga, M. Ibáñez, A. R. Cid, S. Haya, F. Ferrando, A. Blanquer, J. Cervera, S. Bonanad

First evidence for a pharmacist-led anticoagulant clinic in a medicare part A long term care environment

Jeffrey A. Gray, Ralph A. Lugo, Vivi N. Patel, Cindy J. Pohland, David W. Stewart

Chronic Lymphocytic Leukemia Letter to the Editor

Ibrutinib related bleeding complications in elderly patients with B cell malignancies

Roberto Castelli, Riccardo Schiavon, Carlo Preti, Giorgio Lambertenghi Deliliers

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.